HOME >> BIOLOGY >> NEWS
Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture

Biomaterials and how they will change our lives

Philadelphia--Robert S. Langer, Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology, has been chosen to deliver the 2001 Ullyot Public Affairs Lecture with a presentation titled "Biomaterials and How They Will Change Our Lives." The lecture, scheduled to take place at the Chemical Heritage Foundation on Thursday, 20 September 2001, will discuss advances in drug delivery that have revolutionized the medical industry. Since joining the MIT faculty in 1977, Langer has specialized in controlled drug delivery and tissue engineering. His discoveries are at the heart of today's multi-billion dollar controlled drug delivery industry and have provided a framework for the emerging technology of tissue engineering. Much of Langer's research has been in biomedical applications of polymers, and his groundbreaking research dispelled the belief that only some sizes of molecules could be delivered slowly.

Langer's later research has led to the development of a number of novel biodegradable polymers with medical applications. One of these resulted in a drug delivery system for the treatment of brain cancer (developed with Dr. Henry Brem of Johns Hopkins University Medical School)-the first FDA-approved treatment for brain cancer in 20 years and the first polymer-based treatment to deliver chemotherapy directly to a tumor site. This treatment has extended the lives of numerous patients and has far fewer side effects than conventional chemotherapy.

Langer has received over eighty major awards. In 1996, he became the only engineer to receive the Gairdner Foundation International Award; fifty-four recipients of this award have subsequently received a Nobel Prize. He received the $500,000 Lemelson-MIT prize, the world's largest prize for invention, in 1998 for being, "one of history's most prolific inventors in medicine," and
'"/>

Contact: Scott P. Lockledge
scottl@chemheritage.org
215-925-2222
Chemical Heritage Foundation
21-Aug-2001


Page: 1 2

Related biology news :

1. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
2. UC Riversides professor Robert Graham elected Fellow of the Soil Science Society of America
3. Robert Horvitz, pioneer in cell death, to be awarded international genetics prize
4. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
5. DFG presents the 2004 MAK and BAT value lists
6. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
7. National study shows dog and cat allergens are universally present in U.S. homes
8. VIB presents its annual results at BIO2004 in San Francisco
9. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
10. AACR awards scholarships to minority and underrepresented scientists
11. Steroid-coated DNA represents new approach to gene delivery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Robert Langer present the Ullyot Public Affairs Lecture

(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/20/2015)... May 20, 2015 NXT-ID, Inc. (NASDAQ: ... wholly owned subsidiary, 3D-ID LLC, a company engaged in ... for the biometrics technology portion of the recently awarded ... the Department of the Army. 3D-ID LLC ... for government, law enforcement and security agencies. ...
(Date:5/19/2015)... 2015  Technology is rapidly advancing, outpacing enterprises, ability ... cloud. Passwords and their management are soon to be ... specifications such as those developed by the FIDO Alliance™. ... presents for BYOD, COPE, IoT, and mobile payments, the ... In response to the call for ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
(Date:5/28/2015)... 28, 2015 Clinerion, an ... Switzerland, and the Alliance for Clinical Research ... non-profit organization operating in the public interest ... to enhance quality, safety, integrity and operational ... research, are pleased to announce their partnership ...
(Date:5/27/2015)... , May 27, 2015 RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... that it has commenced a public offering of ... shares of its common stock and overallotment purchase ... The shares of common stock, warrants and overallotment ...
(Date:5/27/2015)... , May 26, 2015 Research ... of the "Global Breast Cancer Monoclonal Antibodies ... Globally, Roche seems to dominate the ... inventory. Its block buster molecule, Herceptin has been ... It was found that breast cancer cells become ...
(Date:5/27/2015)... Expanding in a big way into ... Biomed Inc. recently inked a deal with Arthur ... Ltd. , the largest endodontic distributor in Japan. The ... for Avalon Biomed, which manufactures Grey MTA Plus® and ... cements that have won renown from dentists around the ...
Breaking Biology Technology:Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3
Cached News: